Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Salvina Therapeutics AG

History from 17 May 2023

UID
CHE-191.062.900
Legal form
AG
Canton
BL
Founded
17 May 2023
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 426k
107k213k320k426k8 Aug 2024 · CHF 316k22 Jan 2026 · CHF 426k20252026
  • shares
  • Vorzugsaktien

Record

  1. Company formed

    Founded 17 May 2023

    SHAB HR01-1005751800 ↗
  2. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    100’000 → 316’483.60
    Shares
    1’000’000 → 3’164’836
    New shares, % of post-step shares
    68.4% (2’164’836 new)
    Share classes
    1’000’000 × CHF 0.10 · 2’164’836 × CHF 0.10 Vorzugsaktien

    Aktienkapital neu: CHF 316'483.60 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 316'483.60 [bisher: CHF 100'000.00]. Aktien neu: 1'000'000 Namenaktien zu CHF 0.10 und 2'164'836 Namenaktien zu CHF 0.10 (Vorzugsaktien) [bisher: 1'000'000 vinkulierte Namenaktien zu CHF 0.10].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006102553 ↗
  3. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    316’483.60 → 426’373.40
    Shares
    3’164’836 → 4’263’734
    New shares, % of post-step shares
    25.8% (1’098’898 new)
    Share classes
    1’000’000 × CHF 0.10 · 3’263’734 × CHF 0.10 Vorzugsaktien

    Aktienkapital neu: CHF 426'373.40 [bisher: CHF 316'483.60]. Liberierung Aktienkapital neu: CHF 426'373.40 [bisher: CHF 316'483.60]. Aktien neu: 1'000'000 vinkulierte Namenaktien zu CHF 0.10 und 3'263'734 vinkulierte Namenaktien zu CHF 0.10 (Vorzugsaktien) [bisher: 2'164'836 Namenaktien zu CHF 0.10 (Vorzugsaktien) und 1'000'000 Namenaktien zu CHF 0.10].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.90 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006546795 ↗

Published by 8 Oct 2026